US Patent 9539254 Mutant ROS expression in human cancer
Patent 9539254 was granted and assigned to Cell Signaling Technology on January, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9539254 Mutant ROS expression in human cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.